State Street’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

State Street’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,758	Closed	-$32.3K	–	4414
2024 Q1	$32.3K	Hold	3,758	–	–	﹤0.01%	4228
2023 Q4	$13.2K	Hold	3,758	–	–	﹤0.01%	4378
2023 Q3	$13.4K	Hold	3,758	–	–	﹤0.01%	4482
2023 Q2	$21.9K	Hold	3,758	–	–	﹤0.01%	4583
2023 Q1	$142K	Hold	3,758	–	–	﹤0.01%	4189
2022 Q4	$112K	Hold	3,758	–	–	﹤0.01%	4339
2022 Q3	$126K	Hold	3,758	–	–	﹤0.01%	4368
2022 Q2	$150K	Hold	3,758	–	–	﹤0.01%	4340
2022 Q1	$198K	Buy	3,758 +110	+3%	+$5.53K	﹤0.01%	4390
2021 Q4	$202K	Hold	3,648	–	–	﹤0.01%	4349
2021 Q3	$282K	Hold	3,648	–	–	﹤0.01%	4226
2021 Q2	$473K	Buy	+3,648	New	+$505K	﹤0.01%	3878

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

State Street's TCON Position: Q2 2024 in Review

State Street sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 3,758 shares — an estimated $32.3K sold.

State Street first reported a position in TCON in Q2 2021 and held it in 12 quarters. The position peaked at $473K in Q2 2021. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

State Street reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
State Street sold 3,758 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $32.3K.
State Street first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
State Street's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $473K in Q2 2021.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.